Khiron Pharma Commerce ApS: Financial statements 2022
CVR: 37003204
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Khiron Pharma Commerce ApS (CVR 37003204) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -60,982 and a net result of DKK -62,129 compared with DKK 54,580 the year before. Equity in the 2022 report amounted to DKK 37,524. The solvency ratio was 9.3%.
- Gross Profit
- DKK -60,982
- Profit/Loss
- DKK -62,129
- Equity
- DKK 37,524
- Total Assets
- DKK 401,859
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -61 t. | -62 t. | 38 t. | 0 |
| 2021 | - | 130 t. | 55 t. | 100 t. | 1 |
| 2020 | - | -33 t. | -69 t. | 45 t. | 1 |
| 2019 | - | 218 t. | 64 t. | 114 t. | 1 |
| 2018 | - | 164 t. | 17 t. | 49 t. | 1 |
Official annual report
Keep an eye on Khiron Pharma Commerce ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Khiron Pharma Commerce ApS has published its annual report for 2021. Gross profit came to DKK 129,585, and the net result was DKK 54,580.
About Khiron Pharma Commerce ApS
Khiron Pharma Commerce ApS is a Danish company of the type Anpartsselskab based in Frederiksværk, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dan Henning Norden and Lone Lindquist-Nielsen. The company's owners include Lone Lindquist-Nielsen, Dan Henning Norden and Mette Rokkedal. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 780,426 and a net result of DKK 339,637 compared with DKK 4,240 the year before. Equity in the 2025 report amounted to DKK 515,211.